SITC

SITC
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $27.1M ▼ | $21.063M ▼ | $-6.158M ▼ | -22.723% ▼ | $-0.13 ▼ | $8.775M ▼ |
| Q2-2025 | $33.47M ▼ | $22.339M ▼ | $46.504M ▲ | 138.942% ▲ | $0.88 ▲ | $64.918M ▲ |
| Q1-2025 | $42.623M ▲ | $22.647M ▲ | $3.085M ▲ | 7.238% ▼ | $0.06 ▲ | $22.051M ▲ |
| Q4-2024 | $-51.058M ▼ | $-8.312M ▼ | $-5.822M ▼ | 11.403% ▼ | $-0.25 ▼ | $6.626M ▼ |
| Q3-2024 | $90.763M | $49.362M | $322.953M | 355.82% | $6.09 | $374.109M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $128.234M ▼ | $653.955M ▼ | $345.669M ▼ | $308.286M ▼ |
| Q2-2025 | $153.789M ▲ | $959.04M ▲ | $472.358M ▲ | $486.682M ▼ |
| Q1-2025 | $58.155M ▲ | $929.755M ▼ | $410.138M ▼ | $519.617M ▲ |
| Q4-2024 | $54.595M ▼ | $933.602M ▼ | $416.858M ▼ | $516.744M ▼ |
| Q3-2024 | $1.063B | $3.127B | $475.172M | $2.652B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-6.994M ▼ | $5.212M ▼ | $261.813M ▲ | $-291.229M ▼ | $-24.204M ▼ | $900K ▼ |
| Q2-2025 | $46.118M ▲ | $17.649M ▲ | $89.649M ▲ | $-14.397M ▼ | $92.901M ▲ | $15.883M ▲ |
| Q1-2025 | $3.07M ▲ | $5.723M ▲ | $-3.25M ▲ | $-518K ▲ | $1.955M ▲ | $2.476M ▲ |
| Q4-2024 | $-5.822M ▼ | $-29.755M ▼ | $-7.46M ▼ | $-979.245M ▲ | $-1.016B ▼ | $-30.678M ▼ |
| Q3-2024 | $322.953M | $36.756M | $1.124B | $-1.262B | $-101.452M | $36.756M |
Revenue by Products
| Product | Q3-2021 | Q4-2021 | Q1-2022 | Q4-2022 |
|---|---|---|---|---|
Asset And Property Management Fees | $0 ▲ | $0 ▲ | $0 ▲ | $10.00M ▲ |
Development Fees | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Leasing Commissions | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
R V I Disposition Fees | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Credit Facility Guaranty | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Disposition Fees | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
SITE Centers is in the middle of a major reshaping: it has sold assets, spun off a separate REIT, and narrowed its focus to high‑quality, open‑air shopping centers in affluent suburbs, especially those anchored by grocery stores and other daily‑needs retailers. The core business shows a track record of improving profitability and steady cash flows, but the latest figures are heavily influenced by one‑off gains from transactions and do not yet represent a settled, post‑spin earnings level. The balance sheet is now leaner and less leveraged, which reduces financial strain but leaves the company smaller and more concentrated. Strategically, its edge rests on strong locations, necessity‑based tenants, redevelopment skills, and some thoughtful sustainability and technology initiatives, rather than on sheer size. Key uncertainties center on how the streamlined portfolio performs over the next few years, how well management deploys capital after the reshaping, and how broader retail and interest‑rate conditions evolve.
NEWS
November 21, 2025 · 4:47 PM UTC
SITE Centers Announces Sales of Four Properties
Read more
November 20, 2025 · 6:29 PM UTC
SITE Centers Announces Sale of Paradise Village Gateway
Read more
November 7, 2025 · 11:30 AM UTC
Akeso Unveils Promising Preclinical Data for IL-1RAP Targeting Antibody (AK135) at SITC 2025
Read more
November 7, 2025 · 9:05 AM UTC
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Read more
November 7, 2025 · 9:01 AM UTC
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Read more
About SITE Centers Corp.
https://www.sitecenters.comSITE Centers is an owner and manager of open-air shopping centers that provide a highly-compelling shopping experience and merchandise mix for retail partners and consumers. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $27.1M ▼ | $21.063M ▼ | $-6.158M ▼ | -22.723% ▼ | $-0.13 ▼ | $8.775M ▼ |
| Q2-2025 | $33.47M ▼ | $22.339M ▼ | $46.504M ▲ | 138.942% ▲ | $0.88 ▲ | $64.918M ▲ |
| Q1-2025 | $42.623M ▲ | $22.647M ▲ | $3.085M ▲ | 7.238% ▼ | $0.06 ▲ | $22.051M ▲ |
| Q4-2024 | $-51.058M ▼ | $-8.312M ▼ | $-5.822M ▼ | 11.403% ▼ | $-0.25 ▼ | $6.626M ▼ |
| Q3-2024 | $90.763M | $49.362M | $322.953M | 355.82% | $6.09 | $374.109M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $128.234M ▼ | $653.955M ▼ | $345.669M ▼ | $308.286M ▼ |
| Q2-2025 | $153.789M ▲ | $959.04M ▲ | $472.358M ▲ | $486.682M ▼ |
| Q1-2025 | $58.155M ▲ | $929.755M ▼ | $410.138M ▼ | $519.617M ▲ |
| Q4-2024 | $54.595M ▼ | $933.602M ▼ | $416.858M ▼ | $516.744M ▼ |
| Q3-2024 | $1.063B | $3.127B | $475.172M | $2.652B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-6.994M ▼ | $5.212M ▼ | $261.813M ▲ | $-291.229M ▼ | $-24.204M ▼ | $900K ▼ |
| Q2-2025 | $46.118M ▲ | $17.649M ▲ | $89.649M ▲ | $-14.397M ▼ | $92.901M ▲ | $15.883M ▲ |
| Q1-2025 | $3.07M ▲ | $5.723M ▲ | $-3.25M ▲ | $-518K ▲ | $1.955M ▲ | $2.476M ▲ |
| Q4-2024 | $-5.822M ▼ | $-29.755M ▼ | $-7.46M ▼ | $-979.245M ▲ | $-1.016B ▼ | $-30.678M ▼ |
| Q3-2024 | $322.953M | $36.756M | $1.124B | $-1.262B | $-101.452M | $36.756M |
Revenue by Products
| Product | Q3-2021 | Q4-2021 | Q1-2022 | Q4-2022 |
|---|---|---|---|---|
Asset And Property Management Fees | $0 ▲ | $0 ▲ | $0 ▲ | $10.00M ▲ |
Development Fees | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Leasing Commissions | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
R V I Disposition Fees | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Credit Facility Guaranty | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Disposition Fees | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
SITE Centers is in the middle of a major reshaping: it has sold assets, spun off a separate REIT, and narrowed its focus to high‑quality, open‑air shopping centers in affluent suburbs, especially those anchored by grocery stores and other daily‑needs retailers. The core business shows a track record of improving profitability and steady cash flows, but the latest figures are heavily influenced by one‑off gains from transactions and do not yet represent a settled, post‑spin earnings level. The balance sheet is now leaner and less leveraged, which reduces financial strain but leaves the company smaller and more concentrated. Strategically, its edge rests on strong locations, necessity‑based tenants, redevelopment skills, and some thoughtful sustainability and technology initiatives, rather than on sheer size. Key uncertainties center on how the streamlined portfolio performs over the next few years, how well management deploys capital after the reshaping, and how broader retail and interest‑rate conditions evolve.
NEWS
November 21, 2025 · 4:47 PM UTC
SITE Centers Announces Sales of Four Properties
Read more
November 20, 2025 · 6:29 PM UTC
SITE Centers Announces Sale of Paradise Village Gateway
Read more
November 7, 2025 · 11:30 AM UTC
Akeso Unveils Promising Preclinical Data for IL-1RAP Targeting Antibody (AK135) at SITC 2025
Read more
November 7, 2025 · 9:05 AM UTC
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Read more
November 7, 2025 · 9:01 AM UTC
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Read more

CEO
David R. Lukes
Compensation Summary
(Year 2024)

CEO
David R. Lukes
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-08-19 | Reverse | 1:4 |
| 2018-05-21 | Reverse | 1:2 |
| 2009-06-09 | Forward | 6501:6250 |
| 2009-03-10 | Forward | 5333:5000 |
| 1998-08-04 | Forward | 2:1 |
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK INC.
34.751M Shares
$255.769M

BLACKROCK, INC.
7.466M Shares
$54.951M

VANGUARD GROUP INC
5.155M Shares
$37.942M

RUSH ISLAND MANAGEMENT, LP
3.33M Shares
$24.511M

WEISS ASSET MANAGEMENT LP
3.095M Shares
$22.779M

FMR LLC
2.758M Shares
$20.296M

IRENIC CAPITAL MANAGEMENT LP
2.605M Shares
$19.176M

STATE STREET CORP
2.293M Shares
$16.874M

NEWTYN MANAGEMENT, LLC
1.937M Shares
$14.254M

JUPITER INVESTMENT MANAGEMENT LTD
1.873M Shares
$13.787M

GEODE CAPITAL MANAGEMENT, LLC
1.664M Shares
$12.245M

NUVEEN, LLC
1.507M Shares
$11.093M

AQR CAPITAL MANAGEMENT LLC
1.367M Shares
$10.064M

JEFFERIES FINANCIAL GROUP INC.
1.354M Shares
$9.967M

MORGAN STANLEY
1.333M Shares
$9.809M

BALYASNY ASSET MANAGEMENT L.P.
1.187M Shares
$8.733M

COHEN & STEERS, INC.
1.166M Shares
$8.579M

APG ASSET MANAGEMENT US INC.
802.381K Shares
$5.906M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
773.973K Shares
$5.696M

UBS GROUP AG
715.962K Shares
$5.269M
Summary
Only Showing The Top 20



